Spun-out from the North Carolina State University Department of Chemistry, NIRvana Sciences is commercializing novel fluorescent dyes with ultra-narrow emissions that will increase the performance of fluorescence-based medical diagnostic and imaging systems and tests. Ultra-narrow emission dyes reduce detection complexities, thereby generating more accurate data for clinicians while also increasing multiplexing capabilities highly desired by researchers. Such advancements in detection and sensitivity support the “Fewer Tests, More Answers” trend to derive more actionable data from each patient sample. The aim is to improve the diagnosis and treatment regimens of patients affected by cancer or infectious disease.
